Evidence map›Paper›PMID 20232449›Full record

ArticleHuman mutation2010

Novel TMEM67 mutations and genotype-phenotype correlates in meckelin-related ciliopathies.

Miriam Iannicelli, Francesco Brancati, Soumaya Mougou-Zerelli, Annalisa Mazzotta, Sophie Thomas, Nadia Elkhartoufi, Lorena Travaglini, Céline Gomes, Gian Luigi Ardissino, Enrico Bertini and 22 more

Abstract read
In one paragraph

Article in Human mutation, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed.

  1. Loss of U11/U12 spliceosome geneLife science alliance · 2026
    Article
  2. Article
  3. Article
  4. Nephronophthisis: a pathological and genetic perspective.Pediatric nephrology (Berlin, Germany) · 2024
    Review
  5. Article
  6. Article
  7. Identification of novelFrontiers in genetics · 2023
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Genotype-phenotype correlates in Joubert syndrome: A review.American journal of medical genetics. Part C, Seminars in medical genetics · 2022
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Miriam IannicelliCasa Sollievo della Sofferenza Hospital, San Giovanni Rotondo and CSS-Mendel Institute, viale Regina Margherita 261, Rome, Italy.
Francesco Brancati
Soumaya Mougou-Zerelli
Annalisa Mazzotta
Sophie Thomas
Nadia Elkhartoufi
Lorena Travaglini
Céline Gomes
Gian Luigi Ardissino
Enrico Bertini
Eugen Boltshauser
Pierangela Castorina
Stefano D'Arrigo
Rita Fischetto
Brigitte Leroy
Philippe Loget
Maryse Bonnière
Lena Starck
Julia Tantau
Barbara Gentilin
Silvia Majore
Dominika Swistun
Elizabeth Flori
Faustina Lalatta
Chiara Pantaleoni
Johannes Penzien
Paola Grammatico
International JSRD Study Group
Bruno Dallapiccola
Joseph G Gleeson
Tania Attie-Bitach
Enza Maria Valente

Funding

Molecular Characterization of Joubert SyndromeR01NS048453 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLEESON, JOSEPH G · 2004 to 2020
$6.0M
Jouberin and Nephrocystin in Joubert SyndromeR01NS052455 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLEESON, JOSEPH G · 2007 to 2015
$3.0M
NINDS NIH HHS NS048453NINDS NIH HHS NS052455NINDS NIH HHS R01 NS048453NINDS NIH HHS R01 NS052455Telethon GGP08145
6 · The paper itself

Abstract

Human ciliopathies are hereditary conditions caused by defects of proteins expressed at the primary cilium. Among ciliopathies, Joubert syndrome and related disorders (JSRD), Meckel syndrome (MKS) and nephronophthisis (NPH) present clinical and genetic overlap, being allelic at several loci. One of the most interesting gene is TMEM67, encoding the transmembrane protein meckelin. We performed mutation analysis of TMEM67 in 341 probands, including 265 JSRD representative of all clinical subgroups and 76 MKS fetuses. We identified 33 distinct mutations, of which 20 were novel, in 8/10 (80%) JS with liver involvement (COACH phenotype) and 12/76 (16%) MKS fetuses. No mutations were found in other JSRD subtypes, confirming the strong association between TMEM67 mutations and liver involvement. Literature review of all published TMEM67 mutated cases was performed to delineate genotype-phenotype correlates. In particular, comparison of the types of mutations and their distribution along the gene in lethal versus non lethal phenotypes showed in MKS patients a significant enrichment of missense mutations falling in TMEM67 exons 8 to 15, especially when in combination with a truncating mutation. These exons encode for a region of unknown function in the extracellular domain of meckelin.

Indexed as

Abnormalities, MultipleDNA Mutational AnalysisFemaleGenotypeHumansKidney Diseases, CysticLiver CirrhosisMembrane ProteinsMutationPhenotypePregnancyPrenatal DiagnosisMembrane ProteinsTMEM67 protein, human

Identifiers

PMID20232449
PMCPMC2918781

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.